Table 1 Baseline features according to TAVI-CT (transcatheter aortic valve implantation-computed tomography) score.

From: TAVI-CT score to evaluate the anatomic risk in patients undergoing transcatheter aortic valve implantation

Feature

Low score (0–2)

Intermediate score (3)

High score (≥ 4)

p value

Patients

74

50

76

Female gender

51 (68.9%)

34 (68.0%)

32 (42.21%)

0.001

Age (years)

81.1 ± 5.4

81.0 ± 6.5

80.4 ± 6.3

0.754

Body mass index (kg/m2)

26.9 ± 4.3

27.5 ± 4.4

27.0 ± 4.4

0.748

Diagnosis

   

0.831

Aortic stenosis

38 (51.4%)

23 (46.0%)

38 (50.0%)

 

Mixed aortic valve disease

36 (48.7%)

27 (54.0%)

38 (50.0%)

 

Surgical risk

   

0.148

Inoperable

1 (1.4%)

0

1 (1.4%)

 

High

43 (58.1%)

36 (76.6%)

53 (71.6%)

 

Intermediate

30 (40.5%)

11 (23.4%)

20 (27.0%)

 

New York Heart Association class

   

0.207

I

1 (1.4%)

0

0

 

II

65 (87.4%)

38 (76.0%)

63 (82.9%)

 

III

8 (10.8%)

12 (24.0%)

12 (15.8%)

 

IV

0

0

1 (1.3%)

 

Logistic EuroSCORE

15.3 ± 10.2

17.0 ± 9.5

17.7 ± 13.7

0.444

EuroSCORE II

2.98 ± 2.08

3.46 ± 2.57

3.85 ± 4.76

0.304

Coronary artery disease

7 (9.5%)

7 (14.0%)

14 (18.4%)

0.285

Prior cardiac surgery

5 (6.8%)

7 (14.0%)

9 (11.8%)

0.394

Prior cerebrovascular event

   

0.871

No

69 (93.2%)

44 (88.0%)

69 (90.7%)

 

Transient ischemic attack

1 (1.4%)

2 (4.0%)

2 (2.6%)

 

Stroke

4 (5.4%)

4 (8.0%)

5 (6.6%)

 

Peripheral artery disease

13 (17.6%)

9 (18.0%)

35 (46.1%)

 

Estimated glomerular filtration rate (mL/min/1.73 m2)

61.7 ± 17.3

59.6 ± 20.1

66.7 ± 21.6

0.114

Chronic obstructive pulmonary disease

18 (24.3%)

16 (32.0%)

25 (32.9%)

0.454